173 related articles for article (PubMed ID: 10683384)
1. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection.
Rentenaar RJ; Gamadia LE; van DerHoek N; van Diepen FN; Boom R; Weel JF; Wertheim-van Dillen PM; van Lier RA; ten Berge IJ
J Clin Invest; 2000 Feb; 105(4):541-8. PubMed ID: 10683384
[TBL] [Abstract][Full Text] [Related]
2. Properties of CD4(+) T cells in human cytomegalovirus infection.
Gamadia LE; Rentenaar RJ; van Lier RA; ten Berge IJ
Hum Immunol; 2004 May; 65(5):486-92. PubMed ID: 15172448
[TBL] [Abstract][Full Text] [Related]
3. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
4. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
Widmann T; Sester U; Gärtner BC; Schubert J; Pfreundschuh M; Köhler H; Sester M
PLoS One; 2008; 3(11):e3634. PubMed ID: 18982061
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
6. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.
Eid AJ; Brown RA; Arthurs SK; Lahr BD; Eckel-Passow JE; Larson TS; Razonable RR
Transpl Int; 2010 May; 23(5):506-13. PubMed ID: 19951371
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
8. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
10. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient.
Benz C; Holz G; Michel D; Awerkiew S; Dries V; Stippel D; Goeser T; Busch DH
Transplantation; 2003 Mar; 75(5):724-7. PubMed ID: 12640316
[TBL] [Abstract][Full Text] [Related]
11. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
12. Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation.
Avetisyan G; Larsson K; Aschan J; Nilsson C; Hassan M; Ljungman P
Bone Marrow Transplant; 2006 Nov; 38(10):687-92. PubMed ID: 17001346
[TBL] [Abstract][Full Text] [Related]
13. A fingerprint left by cytomegalovirus infection in the human T cell compartment.
van de Berg PJ; van Stijn A; Ten Berge IJ; van Lier RA
J Clin Virol; 2008 Mar; 41(3):213-7. PubMed ID: 18061537
[TBL] [Abstract][Full Text] [Related]
14. Rapid generation of CMV pp65-specific T cells for immunotherapy.
Bao L; Sun Q; Lucas KG
J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
[TBL] [Abstract][Full Text] [Related]
15. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
16. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals.
Tanaka N; Kimura H; Hoshino Y; Nishikawa K; Kojima S; Nishiyama Y; Morishima T
Arch Virol; 2002 Dec; 147(12):2405-17. PubMed ID: 12491106
[TBL] [Abstract][Full Text] [Related]
17. Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients.
Couzi L; Pitard V; Netzer S; Garrigue I; Lafon ME; Moreau JF; Taupin JL; Merville P; Déchanet-Merville J
J Infect Dis; 2009 Nov; 200(9):1415-24. PubMed ID: 19780672
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection.
Lilleri D; Fornara C; Revello MG; Gerna G
J Infect Dis; 2008 Aug; 198(4):536-43. PubMed ID: 18590456
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus (CMV)-specific cellular immune responses.
Harari A; Zimmerli SC; Pantaleo G
Hum Immunol; 2004 May; 65(5):500-6. PubMed ID: 15172450
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of cytomegalovirus-specific cell-mediated immunity in the congenital infection.
Hayashi N; Kimura H; Morishima T; Tanaka N; Tsurumi T; Kuzushima K
J Med Virol; 2003 Oct; 71(2):251-8. PubMed ID: 12938200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
